首页> 外文期刊>Cost Effectiveness Resource Allocation >Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review
【24h】

Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review

机译:使用残疾调整生命年的疟疾干预措施的成本效益分析:系统评价

获取原文
获取外文期刊封面目录资料

摘要

BackgroundMalaria continues to be a public health problem despite past and on-going control efforts. For sustenance of control efforts to achieve the malaria elimination goal, it is important that the most cost-effective interventions are employed. This paper reviews studies on cost-effectiveness of malaria interventions using disability-adjusted life years. MethodsA review of literature was conducted through a literature search of international peer-reviewed journals as well as grey literature. Searches were conducted through Medline (PubMed), EMBASE and Google Scholar search engines. The searches included articles published in English for the period from 1996 to 2016. The inclusion criteria for the study were type of malaria intervention, year of publication and cost-effectiveness ratio in terms of cost per DALY averted. We included 40 studies which specifically used the DALY metric in cost-effectiveness analysis (CEA) of malaria interventions. ResultsThe majority of the reviewed studies (75%) were done using data from African settings with the majority of the interventions (60.0%) targeting all age categories. Interventions included case treatment, prophylaxis, vector control, insecticide treated nets, early detection, environmental management, diagnosis and educational programmes. Sulfadoxine–pyrimethamine was the most common drug of choice in malaria prophylaxis, while artemisinin-based combination therapies were the most common drugs for case treatment. Based on guidelines for CEA, most interventions proved cost-effective in terms of cost per DALYs averted for each intervention. ConclusionThe DALY metric is a useful tool for determining the cost-effectiveness of malaria interventions. This paper demonstrates the importance of CEA in informing decisions made by policy makers.
机译:背景技术尽管过去和正在进行的控制努力,疟疾仍然是公共卫生问题。为了维持控制工作以实现消除疟疾的目标,采用最具成本效益的干预措施非常重要。本文回顾了使用残疾调整生命年的疟疾干预措施成本效益的研究。方法通过对国际同行评审期刊以及灰色文献进行文献检索来进行文献综述。搜索通过Medline(PubMed),EMBASE和Google Scholar搜索引擎进行。搜索包括1996年至2016年期间以英文发表的文章。该研究的纳入标准为疟疾干预措施的类型,出版年份和就避免DALY的成本而言的成本效益比。我们纳入了40项研究,这些研究专门将DALY指标用于疟疾干预措施的成本效益分析(CEA)。结果:大多数回顾性研究(75%)是使用非洲地区的数据完成的,大多数干预措施(60.0%)针对所有年龄段。干预措施包括病例治疗,预防,病媒控制,杀虫剂处理过的蚊帐,及早发现,环境管理,诊断和教育计划。磺胺多辛-乙胺嘧啶是预防疟疾中最常用的药物,而基于青蒿素的联合疗法则是用于病例治疗的最常用药物。根据CEA指南,就每项干预措施避免的每位DALY的成本而言,大多数干预措施被证明具有成本效益。结论DALY指标是确定疟疾干预措施成本效益的有用工具。本文证明了CEA在告知政策制定者决策中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号